300677 英科医疗
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入7,424,7154.60%9,523,3176,918,7246,613,81416,240,094
减:营业总成本6,860,9357.32%8,106,2026,753,5606,051,3327,580,925
    其中:营业成本5,665,1182.89%7,272,3485,971,0235,745,7176,251,626
               财务费用126,812-460.90%(436,625)(306,436)(627,253)(19,180)
               资产减值损失9,977-719.66%(109,053)(5,349)(44,038)(5,744)
公允价值变动收益245,296658.08%279,767175,56759,67032,661
投资收益183,278271.38%63,17787,44683,27128,458
    其中:对联营企业和合营企业的投资收益------------
营业利润1,065,87535.63%1,676,824438,990707,1848,688,725
利润总额1,060,49235.99%1,608,918442,818704,4148,648,693
减:所得税费用108,87836.01%117,22954,75365,0711,185,221
净利润951,61335.99%1,491,689388,065639,3437,463,471
减:非控股权益27,202120.84%26,2135,06710,27333,395
股东净利润924,41134.47%1,465,476382,998629,0707,430,076

市场价值指针
每股收益 (元) *1.45038.10%2.2600.5800.95011.330
每股派息 (元) *0.0500.00%0.1500.0800.1000.750
每股净资产 (元) *27.7347.77%26.93324.43423.96528.879
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容